Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis

被引：0
|
作者：
Xiangyu Kong
Yiqi Du
Guokun Wang
Jun Gao
Yanfang Gong
Lei Li
Zhuo Zhang
Jiaqi Zhu
Qing Jing
Yongwen Qin
Zhaoshen Li
机构：
[1] Second Military Medical University,Department of Gastroenterology, Changhai Hospital
[2] Second Military Medical University,Department of Cardiology, Changhai Hospital
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Pancreatic cancer; Serum microRNA; Biomarker; miR-196a;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：602 / 609
页数：7
相关论文
共 50 条
  • [1] Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis
    Kong, Xiangyu
    Du, Yiqi
    Wang, Guokun
    Gao, Jun
    Gong, Yanfang
    Li, Lei
    Zhang, Zhuo
    Zhu, Jiaqi
    Jing, Qing
    Qin, Yongwen
    Li, Zhaoshen
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (02) : 602 - 609
  • [2] Erratum to: Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis
    Xiangyu Kong
    Yiqi Du
    Guokun Wang
    Jun Gao
    Yanfang Gong
    Lei Li
    Zhuo Zhang
    Jiaqi Zhu
    Qing Jing
    Yongwen Qin
    Zhaoshen Li
    Digestive Diseases and Sciences, 2011, 56 (3) : 921 - 921
  • [3] Differential Expression of miR-196a and miR-216a in Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
    Lai, J.
    Larson, B. K.
    Thakur, S.
    Sahu, S. S.
    Agarwal, S.
    Guindi, M.
    Kalra, K.
    Dhall, D.
    Pillai, R. K.
    MODERN PATHOLOGY, 2014, 27 : 451A - 451A
  • [4] Differential Expression of miR-196a and miR-216a in Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
    Lai, J.
    Larson, B. K.
    Thakur, S.
    Sahu, S. S.
    Agarwal, S.
    Guindi, M.
    Kalra, K.
    Dhall, D.
    Pillai, R. K.
    LABORATORY INVESTIGATION, 2014, 94 : 451A - 451A
  • [5] Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
    Saukkonen, Kapo
    Hagstrom, Jaana
    Mustonen, Harri
    Juuti, Anne
    Nordling, Stig
    Fermer, Christian
    Nilsson, Olle
    Seppanen, Hanna
    Haglund, Caj
    PLOS ONE, 2015, 10 (06):
  • [6] Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively
    Yu, Qi
    Xu, Changqing
    Yuan, Wei
    Wang, Chengfeng
    Zhao, Ping
    Chen, Lianzhen
    Ma, Jie
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [7] Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients
    Sun, BoLin
    Liu, Xiaogang
    Gao, Yewu
    Li, Li
    Dong, ZhenLing
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2016, 73 (04) : 152 - 157
  • [8] Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma
    Wu, Zhengrong
    Zhou, Liangjing
    Ding, Guoping
    Cao, Liping
    CANCER BIOMARKERS, 2017, 18 (01) : 35 - 39
  • [9] Proteomic analysis of differentially expressed proteins in serum of pancreatic ductal adenocarcinoma
    Chen, Jiong
    Chen, Long-Jiang
    Ma, Xiao-lei
    Wu, Wen
    Zhao, Yue
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E112 - E112
  • [10] Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma
    Tang, Rui
    Ji, Jianmei
    Ding, Jun
    Huang, Jinxin
    Gong, Biao
    Zhang, Xiwen
    Li, Fu
    CELL CYCLE, 2020, 19 (13) : 1602 - 1610
12345